The Impact of Facility Type and Volume on Treatment and Overall Survival in Craniopharyngioma
Neuromedin B receptor as a potential therapeutic target for corticotroph adenomas
Validation of criteria for defining Pituitary Tumors Centers of Excellence (PTCOE)
Health-Related Quality of Life Analyses in Nonfunctioning Pituitary Macroadenoma Patients Identifies At-Risk Populations
[68Ga]-DOTATATE PET/MR-based Evaluation of Physiologic Somatostatin Receptor 2 Expression in the Adult Pituitary Gland as a Function of Age and Sex in a Prospective Cohort.
The Acromegaly Treatment Satisfaction Questionnaire (Acro-TSQ): Turkish adaptation, validity, and reliability study
Usefulness of a five-tiered clinicopathological classification in predicting treatment-related outcomes and multimodal therapeutic approaches in pituitary adenoma patients: retrospective analysis on a Portuguese cohort of 129 patients from a tertiary pituitary center
Clinical and Imaging Findings for the Evaluation of Large Rathke’s Cleft Cysts and Cystic Craniopharyngiomas
Antiplatelet and Anticoagulation Therapy and the Risk of Pituitary Apoplexy in Pituitary Adenoma Patients
Importance of 24 Hours Ambulatory Blood Pressure Monitoring in Patients With Acromegaly and Correlation With Cardiac Magnetic Resonance Findings